The Question Isn’t Whether FDA Can Move Faster. It’s Whether You Can. What FDA’s proposed Expedited IND Pilot reveals about operational readiness for clinical trial sponsors. Why This Matters FDA’s proposed Expedited IND Pilot has generated considerable interest because of its potential to accelerate early clinical development. But after listening to the FDA webinar on […]
